Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ AVANIR PHARMACEUTICALS INC., Plaintiff-Appellee AVANIR HOLDING COMPANY, CENTER FOR NEUROLOGICAL STUDY, Plaintiffs v. PAR PHARMACEUTICAL INC., PAR PHARMACEUTICAL COMPANIES INC., Defendants-Appellants ______________________ 2014-1838 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:11-cv-00704-LPS, Chief Judge Leonard P. Stark. ______________________ JUDGMENT ______________________ F. DOMINIC CERRITO, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for plaintiff- appellee. Also represented by ERIC C. STOPS, EVANGELINE SHIH, DANIEL C. WIESNER.
JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, argued for defendants-appellants. Also represented by RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO ANDERSON, STEPHEN YANG. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (CHEN, LINN, and HUGHES, Circuit Judg- es).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
August 10, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.